7. A multi-dimensional storm for Pharma… R&D productivity Increasing payor power Regulatory conservatism Patent cliffs Decentralisation of healthcare Changing customer and societal expectations Implications for Pharma: Growth Risk + Excess global capacity = New business model needed
8. Different approaches and behaviours Co-dependent partners Short-term focus Long-term strategic focus All parties need to adapt and engage with each other differently A more strategic relationship is required Procurer Supplier
24. Improving quality and productivity in the management of COPD Developing Joined-up ways of working to improve COPD An ABPI/DH defined Joint Working project between StHealth PBC Consortium and GlaxoSmithKline (GSK).